Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Basilea Pharmaceutica AG Appoints Ronald Scott As CEO To Succeed Anthony Man


Monday, 10 Dec 2012 01:25am EST 

Basilea Pharmaceutica AG announced that it has promoted Ronald Scott, previously Chief Operating Officer, to Chief Executive Officer (CEO) effective January 1, 2013 to succeed Anthony Man, who has decided for personal reasons to leave the Company as of December 31, 2012.